Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3799039
Max Phase: Preclinical
Molecular Formula: C25H27N3O4
Molecular Weight: 433.51
Molecule Type: Small molecule
Associated Items:
ID: ALA3799039
Max Phase: Preclinical
Molecular Formula: C25H27N3O4
Molecular Weight: 433.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)NC(=O)C(c1ccc2c(c1)OCO2)N1CCc2c([nH]c3ccccc23)CC1=O
Standard InChI: InChI=1S/C25H27N3O4/c1-25(2,3)27-24(30)23(15-8-9-20-21(12-15)32-14-31-20)28-11-10-17-16-6-4-5-7-18(16)26-19(17)13-22(28)29/h4-9,12,23,26H,10-11,13-14H2,1-3H3,(H,27,30)
Standard InChI Key: RLSLDGQGGMQYGX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 433.51 | Molecular Weight (Monoisotopic): 433.2002 | AlogP: 3.48 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.66 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.82 | CX LogD: 2.82 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.66 | Np Likeness Score: -0.51 |
1. Rentería-Gómez A, Islas-Jácome A, Díaz-Cervantes E, Villaseñor-Granados T, Robles J, Gámez-Montaño R.. (2016) Synthesis of azepino[4,5-b]indol-4-ones via MCR/free radical cyclization and in vitro-in silico studies as 5-Ht₆R ligands., 26 (9): [PMID:26996373] [10.1016/j.bmcl.2016.03.036] |
Source(1):